Jinhe Biotechnology Co Ltd Tangible Net Worth Ratio
Jinhe Biotechnology Co Ltd tangible net worth ratio. Jinhe Biotechnology Co Ltd (002688) has a Tangible Net Worth Ratio of 73.2% as of September 2025. This metric is calculated by deducting intangible assets (CN¥696.51 Million) from net assets (CN¥2.60 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check strategic asset allocation of Jinhe Biotechnology Co Ltd to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Jinhe Biotechnology Co Ltd (2008–2024)
Tangible net worth ratio of Jinhe Biotechnology Co Ltd from 2008 to 2024. This chart shows how Jinhe Biotechnology Co Ltd's Tangible Net Worth Ratio has changed across 17 annual periods from 2008 to 2024. As of September 2025, the ratio stands at 73.2%, reflecting net assets of CN¥2.60 Billion with intangible assets of CN¥696.51 Million CNY. See Jinhe Biotechnology Co Ltd (002688) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Jinhe Biotechnology Co Ltd Tangible Net Worth Ratio by Year (2008–2024)
Jinhe Biotechnology Co Ltd tangible net worth ratio by year from 2008 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Jinhe Biotechnology Co Ltd from 2008 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 002688 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 71.4% | CN¥2.50 Billion | CN¥715.26 Million | CN¥5.65 Billion | ▲ +0.9 pp |
| 2023 | 70.4% | CN¥2.52 Billion | CN¥743.71 Million | CN¥5.45 Billion | ▼ -0.2 pp |
| 2022 | 70.7% | CN¥2.43 Billion | CN¥710.71 Million | CN¥4.51 Billion | ▼ -2.8 pp |
| 2021 | 73.5% | CN¥2.70 Billion | CN¥714.45 Million | CN¥4.06 Billion | ▲ +12.6 pp |
| 2020 | 60.9% | CN¥1.75 Billion | CN¥683.37 Million | CN¥3.38 Billion | ▲ +1.6 pp |
| 2019 | 59.3% | CN¥1.81 Billion | CN¥735.22 Million | CN¥3.34 Billion | ▲ +0.1 pp |
| 2018 | 59.2% | CN¥1.78 Billion | CN¥726.44 Million | CN¥3.34 Billion | ▲ +1.3 pp |
| 2017 | 57.9% | CN¥1.64 Billion | CN¥689.33 Million | CN¥2.96 Billion | ▲ +1.9 pp |
| 2016 | 56.0% | CN¥1.58 Billion | CN¥697.05 Million | CN¥2.66 Billion | ▼ -17.3 pp |
| 2015 | 73.3% | CN¥1.05 Billion | CN¥281.39 Million | CN¥1.89 Billion | ▼ -3.4 pp |
| 2014 | 76.7% | CN¥956.13 Million | CN¥222.39 Million | CN¥1.52 Billion | ▼ -19.9 pp |
| 2013 | 96.6% | CN¥900.07 Million | CN¥30.25 Million | CN¥1.02 Billion | ▲ +0.2 pp |
| 2012 | 96.4% | CN¥863.55 Million | CN¥30.91 Million | CN¥1.00 Billion | ▲ +5.8 pp |
| 2011 | 90.6% | CN¥334.40 Million | CN¥31.37 Million | CN¥670.84 Million | ▲ +2.8 pp |
| 2010 | 87.8% | CN¥254.83 Million | CN¥30.98 Million | CN¥623.92 Million | ▼ -5.8 pp |
| 2009 | 93.7% | CN¥196.03 Million | CN¥12.39 Million | CN¥618.59 Million | ▲ +0.7 pp |
| 2008 | 93.0% | CN¥177.82 Million | CN¥12.47 Million | CN¥566.45 Million | — |